AU2001284038A1 - Sgk2 and sgk3 used as diagnostic and therapeutic targets - Google Patents

Sgk2 and sgk3 used as diagnostic and therapeutic targets

Info

Publication number
AU2001284038A1
AU2001284038A1 AU2001284038A AU2001284038A AU2001284038A1 AU 2001284038 A1 AU2001284038 A1 AU 2001284038A1 AU 2001284038 A AU2001284038 A AU 2001284038A AU 2001284038 A AU2001284038 A AU 2001284038A AU 2001284038 A1 AU2001284038 A1 AU 2001284038A1
Authority
AU
Australia
Prior art keywords
sgk2
sgk3
diagnostic
therapeutic targets
targets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001284038A
Other versions
AU2001284038B2 (en
Inventor
Philip Cohen
Bjorn Friedrich
Florian Lang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10042137A external-priority patent/DE10042137A1/en
Application filed by Individual filed Critical Individual
Publication of AU2001284038A1 publication Critical patent/AU2001284038A1/en
Application granted granted Critical
Publication of AU2001284038B2 publication Critical patent/AU2001284038B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001284038A 2000-08-28 2001-08-28 Sgk2 and SGK3 used as diagnostic and therapeutic targets Ceased AU2001284038B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10042137.7 2000-08-28
DE10042137A DE10042137A1 (en) 2000-08-28 2000-08-28 sgk2 and sgk3 as diagnostic and therapeutic targets
PCT/EP2001/009890 WO2002017893A2 (en) 2000-08-28 2001-08-28 Sgk2 and sgk3 used as diagnostic and therapeutic targets

Publications (2)

Publication Number Publication Date
AU2001284038A1 true AU2001284038A1 (en) 2002-06-06
AU2001284038B2 AU2001284038B2 (en) 2007-03-22

Family

ID=7653998

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001284038A Ceased AU2001284038B2 (en) 2000-08-28 2001-08-28 Sgk2 and SGK3 used as diagnostic and therapeutic targets
AU8403801A Pending AU8403801A (en) 2000-08-28 2001-08-28 Sgk2 and sgk3 used as diagnostic and therapeutic targets

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU8403801A Pending AU8403801A (en) 2000-08-28 2001-08-28 Sgk2 and sgk3 used as diagnostic and therapeutic targets

Country Status (18)

Country Link
US (1) US20040038882A1 (en)
EP (1) EP1313476B1 (en)
JP (1) JP2004507493A (en)
CN (1) CN1193756C (en)
AT (1) ATE343386T1 (en)
AU (2) AU2001284038B2 (en)
CA (1) CA2419472A1 (en)
CY (1) CY1105942T1 (en)
DE (2) DE10042137A1 (en)
DK (1) DK1313476T3 (en)
ES (1) ES2275713T3 (en)
HK (1) HK1061801A1 (en)
HU (1) HUP0302938A3 (en)
MX (1) MXPA03001739A (en)
PL (1) PL359714A1 (en)
PT (1) PT1313476E (en)
RU (1) RU2310471C2 (en)
WO (1) WO2002017893A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10346913A1 (en) * 2003-10-09 2005-05-04 Merck Patent Gmbh acylhydrazone
RU2006135654A (en) * 2004-03-11 2008-09-10 Мерк Патент ГмбХ (DE) METHODS FOR MODULATION OF GLUTAMATE RECEPTORS FOR TREATMENT OF NEUROPSYCHIATRIC DISORDERS, INCLUDING THE APPLICATION OF SERUM AND KLUCKORTICOID KINASE MODULATORS
WO2005118832A2 (en) * 2004-06-01 2005-12-15 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl)
DE102007002717A1 (en) 2007-01-18 2008-07-24 Merck Patent Gmbh Heterocyclic indazole derivatives
DE102007022565A1 (en) 2007-05-14 2008-11-20 Merck Patent Gmbh Heterocyclic indazole derivatives
DE102008029072A1 (en) * 2008-06-10 2009-12-17 Lang, Florian, Prof. Dr.med. Substance, which inhibits serum and glucocorticoid dependent kinase 3, useful for the prophylaxis and/or treatment or diagnosis of age-related diseases e.g. arteriosclerosis, skin atrophy, myasthenia, infertility, stroke and kyphosis
DE102008038222A1 (en) 2008-08-18 2010-02-25 Merck Patent Gmbh Indazol-5-carboxylic acid derivatives
DE102008038221A1 (en) 2008-08-18 2010-02-25 Merck Patent Gmbh 7-azaindole derivatives
DE102008038220A1 (en) 2008-08-18 2010-02-25 Merck Patent Gmbh oxadiazole
EP2177510A1 (en) 2008-10-17 2010-04-21 Universität des Saarlandes Allosteric protein kinase modulators
DE102008059133A1 (en) 2008-11-26 2010-05-27 Merck Patent Gmbh Difluorophenyl diacylhydrazide derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242397A (en) * 1989-06-20 1993-09-07 Cedars-Sinai Medical Center Catheter device and method of use for intramural delivery of protein kinase C and tyrosine protein kinase inhibitors to prevent restenosis after balloon angioplasty
US5385915A (en) * 1990-05-16 1995-01-31 The Rockefeller University Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation
US5137912A (en) * 1991-01-28 1992-08-11 National Science Council Of Republic Of China Chelerythrine inhibits platelet aggregation--a potential anti-aggregation drug
US5243397A (en) * 1992-11-25 1993-09-07 Elop-Electrooptics Industries Ltd. Distance measuring system
GB9325395D0 (en) * 1993-12-11 1994-02-16 Ciba Geigy Ag Compositions
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US6083920A (en) * 1995-12-21 2000-07-04 Ayurcore, Inc. Compositions for modulating intracellular inositol trisphosphate concentration
DE19708173A1 (en) * 1997-02-28 1998-09-03 Dade Behring Marburg Gmbh Cell volume regulated human kinase h-sgk
EP0887081B1 (en) * 1997-06-27 2003-04-23 Smithkline Beecham Corporation Human serum glucocorticoid regulated kinase, a target for chronic renal disease and diabetic nephropathy
EP0889127A1 (en) * 1997-07-01 1999-01-07 Smithkline Beecham Corporation Serine/threonine protein kinase (H-SGK2)
CO4940430A1 (en) * 1997-07-07 2000-07-24 Novartis Ag POLYCLIC COMPOUNDS CONTAINING HYDROGENATED STAUROSPORIN WITH CONVENIENT PHARMACOLOGICAL PROPERTIES AND AN INHIBITING EFFECT ON THE GROWTH OF TUMOR CELLS
CA2274776C (en) * 1997-10-08 2008-11-25 Noboru Kaneko Method for analyzing annexin v in urine and use thereof
US6162613A (en) * 1998-02-18 2000-12-19 Vertex Pharmaceuticals, Inc. Methods for designing inhibitors of serine/threonine-kinases and tyrosine kinases
WO1999061039A2 (en) * 1998-05-22 1999-12-02 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Novel composition for modulating ischemic cell death
DE19917990A1 (en) * 1999-04-20 2000-11-02 Florian Lang Medicament containing inhibitors of cell volume regulated human kinase h-sgk
ATE441107T1 (en) * 2002-03-01 2009-09-15 Siemens Healthcare Diagnostics ASSAY FOR MONITORING CANCER PATIENTS BASED ON LEVELS OF THE EXTRACELLULAR DOMAIN (ECD) ANALYTE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), ALONE OR IN COMBINATION WITH OTHER ANALYTES, IN BODY FLUID SAMPLES

Similar Documents

Publication Publication Date Title
AU2001264297A1 (en) Microcontactor probe and electric probe unit
AU2001257127A1 (en) Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2002218026A1 (en) Cardiovascular disease diagnostic and therapeutic targets
AU4853701A (en) Medical combinations comprising tiotropium and budesonide
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
AUPQ886100A0 (en) Diagnostic test
AU1425801A (en) Field test chamber arrangement
AU2001248214A1 (en) Device for the introduction of medical items
AU2001295322A1 (en) Skin testing device
AU1732101A (en) Game device
AU7377200A (en) Combination therapy including camptothecin
AUPQ155799A0 (en) Therapeutic methods and uses
AU2001284038A1 (en) Sgk2 and sgk3 used as diagnostic and therapeutic targets
HUP0302938A3 (en) Sgk2 and sgk3 used as diagnostic and therapeutic targets
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU1955201A (en) Insecticide targets and methods of use
AU6835300A (en) Diagnostic kit and use thereof
AU2001274172A1 (en) Novel needle for medical device and device comprising same
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AUPR186000A0 (en) Elapsed time indicator
AU3570900A (en) Arrangement and procedure for testing and improving the physical condition and technical skill of sportsmen
AU2001215965A1 (en) Retrofit patch and/or test panel
AU6262601A (en) Phospholipase d effectors for therapy and screening
AU2001252235A1 (en) A composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer